Four Thought Financial Partners, LLC Astrazeneca PLC Transaction History
Four Thought Financial Partners, LLC
- $963 Billion
- Q4 2024
A detailed history of Four Thought Financial Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Four Thought Financial Partners, LLC holds 89,856 shares of AZN stock, worth $6.67 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
89,856
Previous 88,012
2.1%
Holding current value
$6.67 Million
Previous $6.86 Billion
14.14%
% of portfolio
0.61%
Previous 0.81%
Shares
9 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...